Australian Commercial Services Stock News

Macmahon Holdings (ASX:MAH) has drawn investor attention after releasing its half year 2025 results, reaffirming FY26 guidance and lifting its fully franked interim dividend to 0.95 cents per share, an increase of 73% on 1H25. See our latest analysis for Macmahon Holdings. The recent earnings beat, higher interim dividend and reaffirmed FY26 guidance appear to have fed into strong momentum, with a 90 day share price return of 42.99% and a very large 3 year total shareholder return. The 1 year...

Endeavour Group has appointed Tim Poole as its next chairman, succeeding interim chair Duncan Makeig after a period of boardroom turnover and leadership changes following the departures of former executive chair Ari Mervis and CEO Steve Donohue. This governance reset introduces an experienced board leader at a time when investors are closely watching how Endeavour balances growth ambitions with regulatory, competitive, and cost pressures. We’ll now examine how the appointment of Tim Poole as...

On 11 February 2026, Neuren Pharmaceuticals Limited (ASX:NEU) announced a share repurchase program authorizing the buyback and cancellation of up to 6,350,631 shares, or 5% of its 126,639,526 issued shares, with the program running until 2 March 2027. This move reduces the future share count relative to current levels, which can increase each remaining share’s claim on any future earnings and cash flows. We’ll now examine how Neuren’s decision to buy back and cancel up to 5% of its shares...

In February 2026, Computershare reported half-year sales of US$1,559.1 million, slightly lower net income of US$280.4 million, raised full-year 2026 Management EPS guidance to about 144 cps (up around 6%), and announced an ordinary franked dividend of A$0.55 per share for the six months ended December 31, 2025. The combination of higher earnings guidance, attributed to momentum across key business lines, lower interest costs and a completed share buyback, together with an increased dividend...

Ansell (ASX:ANN) has just reported half year 2025 results, with net income of US$88.8 million and basic EPS from continuing operations of US$0.615, along with a higher interim dividend and a completed A$47.2 million buyback. See our latest analysis for Ansell. At a share price of A$33.51, Ansell’s 1-day and 7-day share price returns of 1.70% and 3.59% suggest a short term lift in sentiment. However, the 90-day share price return of 6.50% and 1-year total shareholder return of 5.04% both point...

Alkane Resources (ASX:ALK) is back in focus after releasing half year 2025 results alongside fresh 2026 production guidance, combining stronger reported sales, higher net income and clearer expectations for gold and antimony output. See our latest analysis for Alkane Resources. Those stronger half year numbers and fresh 2026 production guidance arrive after a sharp shift in sentiment, with the share price at A$1.68 and a 90 day share price return of 86.67%. This has fed into a very large 1...

APA Group recently reported half-year 2025 results showing sales of A$1,599 million and net income of A$81 million, with basic earnings per share from continuing operations at A$0.073. Alongside earnings growth, APA is pushing ahead with a A$480 million Stage 3 expansion of its East Coast Gas Grid, aiming to lift pipeline capacity and reinforce its role in Australia’s energy infrastructure. Now we’ll explore how APA’s earnings improvement and A$480 million East Coast Gas Grid expansion...

Lovisa earnings spark fresh look at recent share performance Lovisa Holdings (ASX:LOV) has just released half year results, with sales of A$500.65 million and net income of A$58.39 million. This has drawn fresh attention to a share price that has retreated in recent months. See our latest analysis for Lovisa Holdings. The earnings release comes after a soft patch for the shares, with a 1 day share price return of 12.8% decline and a 30 day share price return of 12.91% decline, while the 5...

nib holdings has recently announced adjustments to its 2026 health insurance premiums across Australian Residents Health Insurance and other segments, reflecting updated regulatory and market conditions. Because premiums are a core revenue lever, these changes may influence nib’s balance between growth, affordability, and claims cost control across its portfolio. We’ll now examine how these 2026 premium adjustments may affect nib holdings’ investment narrative, particularly around revenue...

FireFly Metals Ltd recently reported half-year results to December 31, 2025, reducing its net loss to A$727,000 from A$5.73 million and cutting basic loss per share from A$0.011 to A$0.0011 year-on-year. This sharp improvement in profitability metrics, while still loss-making, points to operational progress that may reshape how investors assess the company’s progress. We’ll now examine how FireFly Metals’ sharply reduced half-year loss might influence its investment narrative and future...

Stockland reported past half-year results to 31 December 2025 showing net income of A$292 million versus A$245 million a year earlier, alongside a declared interim distribution of A$0.09 per security paid on 27 February 2026 and board expectations for full-year 2026 distributions to match the prior year's A$0.252 per security. The combination of higher earnings per share from continuing operations and confidence in maintaining the total annual distribution highlights management’s focus on...

Sandfire Resources Limited has released its half-year results for the period to 31 December 2025, reporting sales of US$672.07 million versus US$572.26 million a year earlier, with net income rising to US$97.06 million and basic earnings per share from continuing operations increasing to US$0.211. This combination of higher revenue and a near doubling of net income highlights a clear uplift in operating profitability over the past year. We’ll now examine how this stronger half-year...

Goodman Group has reported its half-year 2025 results, with sales rising to A$135.1 million while revenue softened to A$1.10 billion and net income edged up to A$824.7 million, alongside slightly lower earnings per share. Alongside these results, Goodman highlighted expanding logistics and data center partnerships, including multi-billion-dollar developments in Europe and the US, underlining the scale of its infrastructure ambitions. We’ll now examine how Goodman’s stronger-than-expected...

Latest Earnings Snapshot Lycopodium (ASX:LYL) has opened H1 2026 earnings season with a mixed recent track record. Trailing twelve month revenue sat around A$334.4 million with EPS of A$1.16, while the prior trailing period showed revenue of about A$333.9 million and EPS of A$1.06. Over the last few reported halves, the company has seen revenue move around the mid A$160 million range per half, with EPS stepping from A$0.52 in H2 2024 to A$0.64 in H1 2025 and A$0.43 in H2 2025. This has set up...

Mesoblast (ASX:MSB) has presented new clinical data for Ryoncil to transplant specialists, reporting consistently high survival outcomes in steroid refractory acute graft versus host disease across multiple patient groups. See our latest analysis for Mesoblast. The latest Ryoncil data arrives after a mixed price run, with Mesoblast’s 90 day share price return of 4.76% contrasting with a 12.64% decline year to date and a three year total shareholder return of 164.49%. This suggests long term...

In recent days, Woolworths Group has come under increased scrutiny ahead of its late-February half-year results, with attention on food retail performance, margin trends, operational upgrades, and ongoing legal challenges in Australia. This combination of operational efficiency initiatives, pricing scrutiny, and regulatory actions is shaping how investors reassess Woolworths’ role within the Australian retail sector. We’ll now examine how regulatory scrutiny over pricing claims and related...

National Australia Bank (ASX:NAB) has kicked off Q1 2026 with a net interest margin of 1.8%, following a 2025 financial year where trailing twelve month revenue was A$20.0 billion and EPS was A$2.22. Over recent quarters, the bank has reported revenue in a range of A$4.90 billion to A$5.21 billion per quarter and quarterly EPS of around A$0.51 to A$0.57, giving investors a clearer view of how earnings are tracking into the new year. With a trailing net profit margin of 33.9%, this update puts...

SHAPE Australia (ASX:SHA) has backed up its latest H1 2026 result with a solid recent track record, with H2 2025 revenue at A$477.9 million and basic EPS of A$0.14, alongside trailing twelve month revenue of A$956.9 million and EPS of A$0.26. The company has seen revenue move from A$423.7 million in H2 2024 to A$478.9 million in H1 2025 and A$477.9 million in H2 2025, while basic EPS has shifted from A$0.10 to A$0.11 and then A$0.14 over the same periods. This gives investors a clear view of...

Clarity Pharmaceuticals recently announced that an abstract from its Co-PSMA Phase II investigator-initiated trial of 64Cu-SAR-bisPSMA has been accepted for oral presentation at the EAU Congress 2026, highlighting data from multiple studies including COBRA, PROPELLER and SECuRE. The trial results indicated that 64Cu-SAR-bisPSMA more than doubled the number of prostate cancer lesions detected per patient versus standard-of-care imaging, with management plans altered in 44% of participants...

Hansen Technologies (ASX:HSN) has backed up its H1 2026 earnings release with a clear lift in the recent run of numbers, with H2 2025 revenue at A$214.2 million, basic EPS of A$0.25 and net income of A$43.3 million. The latest trailing 12 month figures point to net profit margins of 11% compared with 6% a year earlier and earnings growth of 105.7% over the same period. The company has seen revenue move from A$185.2 million in H2 2024 to A$178.3 million in H1 2025 and then A$214.2 million in...

Sonic Healthcare Limited has reported its half-year 2025 results for the period to 31 December 2025, with sales rising to A$5,445.04 million and net income increasing to A$262.49 million, lifting both basic and diluted earnings per share from continuing operations. This marks a shift after a period of weaker profitability, as the company converted higher revenue into improved earnings per share while maintaining consistency between basic and diluted results. We’ll examine how this rebound in...

Australian Foundation Investment Company Limited reported its H1 2026 results on 16 February 2026, outlining portfolio performance, income trends and capital management updates during its earnings call. The call gave investors fresh insight into how the listed investment company is positioning its portfolio in response to evolving market conditions and dividend flows. We’ll now examine how the H1 2026 earnings call, particularly its discussion of portfolio positioning, may shape Australian...

XRF Scientific (ASX:XRF) has just put fresh numbers on the table, with H1 2026 results sitting against a backdrop where revenue in H2 2025 was A$30.7 million and basic EPS was A$0.038, alongside trailing twelve month revenue of A$59.4 million and EPS of A$0.074. Over the past few halves the company has seen revenue move from A$31.5 million in H2 2024 to A$28.7 million in H1 2025 and A$30.7 million in H2 2025, while basic EPS has ranged from A$0.0319 to A$0.038. This sets up a story where...

Chrysos (ASX:C79) has just posted its H1 2026 numbers, with the latest half-year profile shaped by prior period revenue of A$37.0 million and a basic EPS loss of A$0.0486, against a current share price of A$8.03. The company has seen revenue move from A$26.4 million in H2 2024 to A$29.1 million in H1 2025 and then A$37.0 million in H2 2025, while basic EPS shifted from a profit of A$0.0209 in H2 2024 to losses of A$0.0227 and A$0.0486 in the following halves, creating a picture in which top...